In summary, the QEP improves IDD by modulating targets such as Wnt5A, CTNNB1, IL-1β, MAPK14, MMP9, and MMP3 and by regulating the Wnt signaling and MAPK/MMP pathways. The gene discussed is CTNNB1; the disease is intervertebral disk degenerative disorder.